Procter & Gamble sued for possible benzene in antiperspirants

A customer hit Procter & Gamble Co. with a proposed class action lawsuit in Florida federal court alleging the consumer products company failed to disclose that Old Spice and Secret antiperspirants may contain benzene, a human carcinogen.

Tova Bryski Alleges She Has Purchased Secret Antiperspirant Products “On Dozens Of Occasions” Over The Past Years, But Would Not Have Done If She Had Known About Possible Adulteration Of Benzene .

Thursday’s filing in U.S. District Court for the Southern District of Florida follows a citizen petition from independent testing lab Valisure, asking the Food and Drug Administration to recall many antiperspirants and spray deodorants that contain levels high benzene levels.

Antiperspirants from Procter & Gamble were among the affected products.

There is no safe level of exposure to benzene, so it is unsuitable for human application as an ingredient in any antiperspirant, according to the lawsuit.

Earlier this year, Valisure reported that various sunscreen products contained benzene. These findings have also given rise to litigation. Johnson & Johnson, which recalled sunscreen products containing benzene, recently agreed to address the issue with consumers.

Causes of action: Florida Deceptive and Unfair Marketing Practices Act; unjust enrichment; breach of implied warranty; breach of express warranty.

Relief: Orders prohibiting Procter & Gamble from selling the products or declaring that they are safe to use; corrective advertising; restitution; damage.

Potential class size: National class, subclass Florida unknown.

Reply: Procter & Gamble did not immediately respond to a request for comment.

Lawyers: Levin Litigation PLLC, Honik LLC and Kanner & Whiteley LLC represent Bryski.

The case is Bryski v. Procter & Gamble Co., SD Fla., No. 0: 21-cv-62285, complaint 11/4/21.

About Jimmie T.

Check Also

Unprecedented approaches to trial wave in opioid crisis litigation

Landmark verdicts and settlements have already occurred in sweeping opioid litigation against big pharma. This …